Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Prospective evaluation of structure-based simulations reveal their ability to predict the impact of kinase mutations on inhibitor binding
Sukrit Singh, Vytautas Gapsys, Matteo Aldeghi, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
January 25, 2021
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models
Clara Lemos, Volker K Schulze, Simon J Baumgart, et al.
Journal of Medicinal Chemistry
|
October 26, 2021
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A
Lars Wortmann, Nico Bräuer, Simon J Holton, et al.
Journal of Medicinal Chemistry
|
April 14, 2017
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains
Léa Bouché, Clara D Christ, Stephan Siegel, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
June 22, 2021
Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening
Stefan Gradl, Holger Steuber, Joerg Weiske, et al.
Journal of Medicinal Chemistry
|
April 15, 2016
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2
Erik Eggert, Roman C Hillig, Silke Koehr, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Prospective evaluation of structure-based simulations reveal their ability to predict the impact of kinase mutations on inhibitor binding
Sukrit Singh, Vytautas Gapsys, Matteo Aldeghi, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
January 25, 2021
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models
Clara Lemos, Volker K Schulze, Simon J Baumgart, et al.
Journal of Medicinal Chemistry
|
October 26, 2021
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A
Lars Wortmann, Nico Bräuer, Simon J Holton, et al.
Journal of Medicinal Chemistry
|
April 14, 2017
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains
Léa Bouché, Clara D Christ, Stephan Siegel, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
June 22, 2021
Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening
Stefan Gradl, Holger Steuber, Joerg Weiske, et al.
Journal of Medicinal Chemistry
|
April 15, 2016
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2
Erik Eggert, Roman C Hillig, Silke Koehr, et al.
Page
of 3